Imunon, Inc. Other Comprehensive Income (Loss), Net of Tax
Imunon, Inc. (IMNN) reported Other Comprehensive Income (Loss), Net of Tax of $3.86 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-24.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2017-11-14
- Imunon, Inc. other comprehensive income (loss), net of tax for the quarter ending 2016-12-31 was -$464.00.
- Imunon, Inc. other comprehensive income (loss), net of tax for the quarter ending 2016-09-30 was $464.00, a 85.86% decline year-over-year.
- Imunon, Inc. other comprehensive income (loss), net of tax for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- Imunon, Inc. other comprehensive income (loss), net of tax for the quarter ending 2016-03-31 was $3.86K, a 52.24% decline year-over-year.
- Imunon, Inc. other comprehensive income (loss), net of tax for fiscal 2016 was $3.86K, a 68.31% decline from fiscal 2015.
- Imunon, Inc. other comprehensive income (loss), net of tax for fiscal 2015 was $12.17K, a 56.73% decline from fiscal 2014.
- Imunon, Inc. other comprehensive income (loss), net of tax for fiscal 2014 was $28.13K, a 65.87% decline from fiscal 2013.
- Imunon, Inc. other comprehensive income (loss), net of tax for fiscal 2013 was $82.44K, a 45.07% decline from fiscal 2012.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$464.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 derived: sum of 3 quarters · filed 2017-11-14 | $3.86K 10-K · filed 2017-03-24 |
| 2016-09-30 | $464.00 10-Q · filed 2017-11-14 | $464.00 derived: sum of 2 quarters · filed 2017-11-14 | $4.32K 10-Q · filed 2017-11-14 | $1.50K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $3.86K 10-Q · filed 2017-08-14 | $1.03K derived: sum of 3 quarters · filed 2017-08-14 | $4.32K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $3.86K 10-Q · filed 2017-05-12 | $1.03K derived: sum of 2 quarters · filed 2017-05-12 | $4.32K derived: sum of 3 quarters · filed 2017-05-12 | $7.95K derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | -$2.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $457.00 derived: sum of 2 quarters · filed 2017-03-24 | $4.10K derived: sum of 3 quarters · filed 2017-03-24 | $12.17K 10-K · filed 2017-03-24 |
| 2015-09-30 | $3.28K 10-Q · filed 2016-11-10 | $6.92K derived: sum of 2 quarters · filed 2016-11-10 | $15.00K 10-Q · filed 2016-11-10 | $25.04K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $3.64K 10-Q · filed 2016-08-15 | $11.72K 10-Q · filed 2016-08-15 | $21.76K derived: sum of 3 quarters · filed 2016-08-15 | $7.51K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $8.08K 10-Q · filed 2016-05-16 | $18.12K derived: sum of 2 quarters · filed 2016-05-16 | $3.88K derived: sum of 3 quarters · filed 2016-05-16 | $19.94K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | $10.04K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$4.20K derived: sum of 2 quarters · filed 2016-03-30 | $11.87K derived: sum of 3 quarters · filed 2016-03-30 | $28.13K 10-K · filed 2016-03-30 |
| 2014-09-30 | -$14.24K 10-Q · filed 2015-11-05 | $1.82K derived: sum of 2 quarters · filed 2015-11-05 | $18.09K 10-Q · filed 2015-11-05 | $279.76K derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-06-30 | $16.07K 10-Q · filed 2015-08-10 | $32.34K 10-Q · filed 2015-08-10 | $294.00K derived: sum of 3 quarters · filed 2016-03-30 | $202.01K derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-03-31 | $16.27K 10-Q · filed 2015-05-11 | $277.93K derived: sum of 2 quarters · filed 2016-03-30 | $185.94K derived: sum of 3 quarters · filed 2016-03-30 | $130.66K derived: sum of 4 quarters · filed 2016-03-30 |
| 2013-12-31 | $261.67K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $169.68K derived: sum of 2 quarters · filed 2016-03-30 | $114.39K derived: sum of 3 quarters · filed 2016-03-30 | $82.44K 10-K · filed 2016-03-30 |
| 2013-09-30 | -$91.99K 10-Q · filed 2014-11-10 | -$147.28K derived: sum of 2 quarters · filed 2014-11-10 | -$179.22K 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -$55.28K 10-Q · filed 2014-08-07 | -$87.23K 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$31.95K 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | $150.09K 10-K · filed 2015-03-12 | |||
| 2011-12-31 | -$258.33K 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |